A Study of HR071603 (Ketamine Nasal Spray) in Healthy Subjects

The study is being conducted to evaluate the safety and pharmacokinetics of HR071603 (ketamine nasal spray) in healthy subjects.

Topic Healthy Subjects
Compound Placebo Ketamine
Country China
Visit trial
Status Completed
Results Published
Start date 24 October 2019
End date 01 July 2021
Chance of happening 100%
Phase Phase I
Design Blinded
Type Interventional
Generation Second
Participants 50
Sex Male
Age 18- 43
Therapy No

Trial Details

The study is being conducted to evaluate the safety and pharmacokinetics of HR071603 (ketamine nasal spray) in healthy subjects.

NCT Number NCT04108234

Sponsors & Collaborators

Jiangsu HengRui Medicine Co
This company doesn't have a full profile yet, it is linked to a clinical trial.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.